Gastric Adenocarcinoma AGS Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 0.5 ml(Cat-117258) | Inquiry | Add to cart | |
| 1.5 ml(Cat-117360) | Inquiry | Add to cart | |
| 8.0 ml(Cat-117461) | Inquiry | Add to cart | |
| 1.5 ml CRISPR(Cat-210559) | Inquiry | Add to cart |
Description
Product Information
Description
Gastric cancer is considered the third leading cause of cancer death worldwide. Due to the lack of early symptoms, it is difficult to detect and is usually diagnosed at a late stage. The AGS gastric adenocarcinoma cell line is a cell line widely used in preclinical studies of gastric cancer. The AGS cell line was originally established in 1979 from the stomach tissue of a 54-year-old Caucasian woman with gastric adenocarcinoma (gastric cancer). These cells exhibit an epithelial morphology and are tumorigenic. The patients had not received any prior treatment before removing these cells. AGS cells can be used in research related to different forms of gastric cancer. In order to facilitate in-depth research, a specific and efficient cell transfection system is essential. To this end, CD BioSciences has developed a specific transfection kit for the AGS cell line.
